| Financial Year |
March 31 2023 |
| Monetary Funds |
1,050,974,879.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,278,832.96 |
| Advances to Suppliers |
6,489,569.77 |
| Other Receivables |
7,241,371.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,794,614,431.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
69,521,202.62 |
| Total Current Assets |
2,930,120,288.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
62,813,924.96 |
| Fixed Assetes |
22,339,904.43 |
| Under-construction Projects |
169,971,690.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,742,598.71 |
| Deferred Income Tax Assets |
53,643,190.73 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
316,391,006.76 |
| Total Assets |
3,246,511,295.06 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
297,136,683.17 |
| Accounts Received In Advance |
364,243.11 |
| Employee Compensation Payable |
18,382,973.39 |
| Taxes Payable |
86,560,809.13 |
| Interest Payable |
16,452,250.00 |
| Dividend Payable |
-- |
| Other payables |
385,850,847.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
232,120,832.03 |
| Other Current Liabilities |
67,225,584.16 |
| Sub-Total of Current Liabilities |
1,838,639,973.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,984,848.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,984,848.58 |
| Total Liabilities |
1,865,624,822.34 |
| Paid-In Capital(Or Share Stock) |
242,046,224.00 |
| Capital Surplus |
9,969,249.97 |
| Surplus Reserve |
247,986,714.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
828,234,482.05 |
| Minority Stockholder's Interest |
52,649,802.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,328,236,670.26 |
| Owner's Equity(Stockholder's Equity) |
1,380,886,472.72 |
| Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,246,511,295.06 |